top of page
A Wholly Owned Subsidiary of
KRTL Holding Group Inc
(OTCIQ: KRTL)
​
KRTL News
All Posts
KRTL Biotech Advances Global Access to Women’s Health Pharmaceuticals Through Strategic Portfolio Expansion
2 days ago
Patricia Wilstermann: A Trailblazing Leader Transforming Bolivia’s Pharmaceutical Industry
7 days ago
KRTL Biotech Highlights Pediatric Product Line to Support Childhood Wellness and Global Public Health
Oct 7
KRTL Biotech Highlights ELIXIR as Flagship Hydration Product in Bolivia
Oct 2
KRTL Biotech Launches Nutraceuticals Initiative in Partnership with SIGMA and Bolivian Health Programs
Sep 30
KRTL Biotech Inc. Introduces Expanded Pharmaceutical Portfolio Following Strategic Acquisition
Sep 25
KRTL Holding Highlights SIGMA’s 50-Year Legacy of Innovation, Quality, and Community Leadership in Bolivia
Sep 23
KRTL Holding Group, Inc. Announces Merger with Industria QuÃmico Farmacéutica Sigma Corp. S.R.L.
Sep 9
KRTL Holding Group, Inc. Reports Strong Year-Over-Year Growth for Second Quarter 2025
Aug 15
KRTL Biotech Inc. Strengthens Import Operations with Official Customs Broker Appointment, Paving the Way for Global API Expansion
Jul 31
KRTL Holding Group Inc. (OTC: KRTL) Bolsters Corporate Leverage with Trademark Recognition and Structural Integration
Jul 2
KRTL Biotech Inc. Advances API Supply Chain Strategy with $240,000 Initial Purchase Order
Jun 12
KRTL Holding Appoints Dave Orn and Rick Haxton to Accelerate Global Growth at KRTL Biotech Inc.
Jun 5
KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative
Jun 4
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
Apr 9
KRTL Holding Group, Inc Commences Trading on Upstream Under KRTL
Apr 2
KRTL Holding Group, Inc Approved to Dual List on Upstream
Mar 25
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria QuÃmico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
Mar 24
KRTL Biotech Implements MasterControl QMS to Enhance Regulatory Compliance and Pharmaceutical Importation Readiness
Mar 3
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director
Feb 12
KRTL Holding Group Inc. Welcomes Dr. Marcelo Bascope as Chief International Science Director
Feb 12
bottom of page
